KRAS genotyping by digital PCR combined with melting curve analysis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
22 02 2019
Historique:
received: 05 11 2018
accepted: 10 01 2019
entrez: 24 2 2019
pubmed: 24 2 2019
medline: 10 9 2020
Statut: epublish

Résumé

Digital PCR (dPCR) has been developed as a method that can quantify nucleic acids more sensitively than real-time PCR. However, dPCR exhibits large fluctuations in the fluorescence intensity of the compartment, resulting in low accuracy. The main cause is most likely due to insufficient PCR. In this study, we proposed a new method that combines dPCR with melting curve analysis and applied that method to KRAS genotyping. Since the melting temperature (Tm) of the PCR product hardly depends on the amplification efficiency, genotyping accuracy is improved by using the Tm value. The results showed that the peaks of the distribution of the Tm values of DNA in the wells were 68.7, 66.3, and 62.6 °C for wild-type KRAS, the G12R mutant, and the G12D mutant, respectively, and the standard deviation of the Tm values was 0.2 °C for each genotype. This result indicates that the proposed method is capable of discriminating between the wild-type sequence and the two mutants. To the best of our knowledge, this is the first demonstration of the genotyping of single mutations by combining melting curve analysis and dPCR. The application of this approach could be useful for the quantification and genotyping of cancer-related genes in low-abundance samples.

Identifiants

pubmed: 30796246
doi: 10.1038/s41598-019-38822-1
pii: 10.1038/s41598-019-38822-1
pmc: PMC6384904
doi:

Substances chimiques

KRAS protein, human 0
Molecular Probes 0
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2626

Références

Anal Biochem. 1999 Sep 10;273(2):221-8
pubmed: 10469493
Cancer Res. 2001 Feb 15;61(4):1659-65
pubmed: 11245480
Clin Chem. 2002 Aug;48(8):1321-8
pubmed: 12142390
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8817-22
pubmed: 12857956
Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8609-14
pubmed: 15937116
Nat Methods. 2006 Jul;3(7):551-9
pubmed: 16791214
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17807-12
pubmed: 17098862
Science. 2006 Dec 1;314(5804):1464-7
pubmed: 17138901
Methods Mol Biol. 2008;429:137-60
pubmed: 18695964
J Clin Microbiol. 2009 Apr;47(4):1190-8
pubmed: 19171684
Scand J Infect Dis. 2010 Aug;42(8):579-85
pubmed: 20429719
PLoS One. 2011 Apr 28;6(4):e19206
pubmed: 21552536
Nat Rev Cancer. 2011 Jun;11(6):426-37
pubmed: 21562580
Lab Chip. 2011 Jul 7;11(13):2167-74
pubmed: 21584334
Anal Chem. 2011 Nov 15;83(22):8604-10
pubmed: 22035192
Nucleic Acids Res. 1990 Nov 11;18(21):6409-12
pubmed: 2243783
Clin Chem. 2013 May;59(5):815-23
pubmed: 23403697
Clin Chem. 2013 Dec;59(12):1722-31
pubmed: 23938455
Anal Chem. 2013 Dec 3;85(23):11619-27
pubmed: 24180464
BMC Microbiol. 2013 Dec 20;13:295
pubmed: 24359556
Nat Commun. 2015 Apr 09;6:6744
pubmed: 25855536
Sci Rep. 2015 Dec 16;5:18425
pubmed: 26669280
Cancer Discov. 2016 May;6(5):479-91
pubmed: 26969689
Clin Transl Gastroenterol. 2016 Mar 24;7:e157
pubmed: 27010960
Sci Rep. 2017 Feb 08;7:42326
pubmed: 28176860
Genome Res. 1996 Oct;6(10):986-94
pubmed: 8908518
Clin Chem. 1997 Dec;43(12):2262-7
pubmed: 9439442

Auteurs

Junko Tanaka (J)

Center for Technology Innovation - Healthcare, Research & Development Group, Hitachi, Ltd.,1-280, Higashi-koigakubo, Kokubunji-shi, Tokyo, 185-8601, Japan. junko.tanaka.gw@hitachi.com.

Tatsuo Nakagawa (T)

Center for Technology Innovation - Healthcare, Research & Development Group, Hitachi, Ltd.,1-280, Higashi-koigakubo, Kokubunji-shi, Tokyo, 185-8601, Japan.

Akiko Shiratori (A)

Center for Technology Innovation - Healthcare, Research & Development Group, Hitachi, Ltd.,1-280, Higashi-koigakubo, Kokubunji-shi, Tokyo, 185-8601, Japan.

Yuzuru Shimazaki (Y)

Center for Technology Innovation - Healthcare, Research & Development Group, Hitachi, Ltd.,1-280, Higashi-koigakubo, Kokubunji-shi, Tokyo, 185-8601, Japan.

Chihiro Uematsu (C)

Center for Technology Innovation - Healthcare, Research & Development Group, Hitachi, Ltd.,1-280, Higashi-koigakubo, Kokubunji-shi, Tokyo, 185-8601, Japan.

Masao Kamahori (M)

Center for Technology Innovation - Healthcare, Research & Development Group, Hitachi, Ltd.,1-280, Higashi-koigakubo, Kokubunji-shi, Tokyo, 185-8601, Japan.

Takahide Yokoi (T)

Center for Technology Innovation - Healthcare, Research & Development Group, Hitachi, Ltd.,1-280, Higashi-koigakubo, Kokubunji-shi, Tokyo, 185-8601, Japan.

Kunio Harada (K)

Center for Technology Innovation - Healthcare, Research & Development Group, Hitachi, Ltd.,1-280, Higashi-koigakubo, Kokubunji-shi, Tokyo, 185-8601, Japan.

Yoshinobu Kohara (Y)

Center for Technology Innovation - Healthcare, Research & Development Group, Hitachi, Ltd.,1-280, Higashi-koigakubo, Kokubunji-shi, Tokyo, 185-8601, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH